Safety-Related Labeling Changes
"Interaction with midazolam hypersensitivity reactions (including anaphylactic reactions, angioedema and urticarial)"
Trade Name
Pafinur
Updated Section
"4.5. Interactions with other medicinal products 4.8 Undesirable effects"
Month
Aug, 2024